10-Year Cardiovascular Risk in Hypertensive Patients: Insights from Central Vietnam Using WHO 2019 Chart

ORIGINAL ARTICLE
Ho Anh Hien, Nguyen Minh Tam, Dirk Devroey, Stefan Heytens, Vo Tam, Tran Binh Thang, Hoang Thi Bach Yen, Doan Pham Phuoc Long, Huynh Van Minh, Hoang Anh Tien

 
For citation: Hien HA, Tam NM, Devroey D, Heytens S, Tam V, Thang TB, Yen HTB, Long DPP, Minh HV, Tien HA. 10-Year Cardiovascular Risk in Hypertensive Patients: Insights from Central Vietnam Using WHO 2019 Chart. International Journal of Biomedicine. 2024;14(2):246-252. doi:10.21103/Article14(2)_OA1
 
Originally published June 5, 2024
 

Abstract: 

Background: Assessing the 10-year cardiovascular disease (CVD) risk is crucial for effective prevention and management. Despite its significance, information is limited on CVD risk among hypertensive patients in primary care in Central Vietnam. We conducted this study to estimate 10-year CVD risk in primary care settings and explore its associated risk factors, using the 2019 WHO CVD risk chart.
Methods and Results: This cross-sectional study collected socio-demographic and clinical data through a standardized questionnaire. Cardiovascular risk was estimated using the WHO CVD risk charts for Southeast Asia. The prevalence of low, moderate, and high CVD risk was 52.1%, 38.9%, and 9.0%, respectively. Notably, men had significantly higher rates of moderate (48.6%) and high (17.6%) CVD risk than women (31.4 and 2.4%, respectively) (P=0.000). Age was a significant factor, with an increasing prevalence of moderate and high CVR as age advanced. Specifically, the 50-59 age group had a moderate risk of 18.6%, rising to 69.9% in the 70-74 age group. High CVD risk increased from 0.6% to 27.6% in the same age groups. Lower educational levels were associated with a higher proportion of moderate CVD risk. Smoking and excessive alcohol consumption were linked to elevated CVD risks (25.0% and 30.0%, respectively), surpassing those without these behaviors. Similar trends were observed for individuals with diabetes, high total cholesterol, and high blood pressure.
Conclusion: Approximately one-tenth of hypertensive patients face a high risk of developing CVDs within the next 10 years. A comprehensive approach, encompassing behavioral changes and the management of metabolic risk factors, is essential to reduce CVD risk effectively.

Keywords: 
blood pressure • hypertension • cardiovascular risk • risk chart
References: 
  1. World Health Organization. Fact sheets: cardiovascular diseases (CVDs). Available from: https://www. who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 25 Dec 2023).
  2. Hillary Ta BS BL and LP. Vietnamese and Vietnamese-American Health Statistics, 2003–2019: Stanford medicine; 2020 [updated March 2020. Available from: https://med.stanford.edu/content/dam/sm/care/VNDataBrief.pdf.
  3. Nguyen TT, Trevisan M. Vietnam a country in transition: health challenges. BMJ Nutr Prev Health. 2020 May 6;3(1):60-66. doi: 10.1136/bmjnph-2020-000069. PMID: 33235972; PMCID: PMC7664505.
  4. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. Erratum in: Eur Heart J. 2022 Nov 7;43(42):4468. PMID: 34458905.
  5. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17. Erratum in: Circulation. 2019 Sep 10;140(11):e649-e650. Erratum in: Circulation. 2020 Jan 28;141(4):e60. Erratum in: Circulation. 2020 Apr 21;141(16):e774. PMID: 30879355; PMCID: PMC7734661.
  6. Hajar R. Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart Views. 2017 Jul-Sep;18(3):109-114. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_106_17. PMID: 29184622; PMCID: PMC5686931.
  7. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22. PMID: 18212285.
  8. WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. doi: 10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2. Erratum in: Lancet Glob Health. 2023 Feb;11(2):e196. PMID: 31488387; PMCID: PMC7025029.
  9. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. PMID: 27222591; PMCID: PMC4986030.
  10. Nguyen TP, Schuiling-Veninga CC, Nguyen TB, Vu TH, Wright EP, Postma MJ. Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community. PLoS One. 2017 Feb 1;12(2):e0171203. doi: 10.1371/journal.pone.0171203. PMID: 28146584; PMCID: PMC5287477.
  11. World Health Organization (WHO). WHO STEPS Surveillance Manual: The WHO STEP-wise Approach to Chronic Disease Risk Factors Surveillance, World Health Organization: Non-communicable Diseases and Mental health, Geneva, World Health Organization. 2005;
  12. Van Minh H, Van Huy T, Long DPP, Tien HA. Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA). J Clin Hypertens (Greenwich). 2022 Sep;24(9):1121-1138. doi: 10.1111/jch.14580. PMID: 36196473; PMCID: PMC9532930.
  13. International Diabetes Institute/ Western Pacific World Health Organization/ International, Force A for the study of OIOT. The Asia-Pacific perspective: redefining obesity and its treatment. Geneva, Switzerland: World Health Organization. 2000. p. 56.
  14. Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence. Br J Clin Pharmacol. 2020 Jul;86(7):1281-1288. doi: 10.1111/bcp.14193. Epub 2020 May 18. PMID: 31823381; PMCID: PMC7319010.
  15. Jaiswal A, Selva Das PA, Singh G, Sathiyamoorthy R, Deori TJ, Dwarakanathan V, Malhotra S, Verma M, Goel S. Assessment of cardiovascular risk using WHO CVD risk prediction chart with respect to hypertension status among Indian population: A secondary analysis of National Family Health Survey (2015-16). J Family Med Prim Care. 2022 Sep;11(9):5757-5765. doi: 10.4103/jfmpc.jfmpc_158_22. Epub 2022 Oct 14. PMID: 36505633; PMCID: PMC9731046.
  16. Hanif AAM, Hasan M, Khan MSA, Hossain MM, Shamim AA, Hossaine M, Ullah MA, Sarker SK, Rahman SMM, Bulbul MMI, Mitra DK, Mridha MK. Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey. PLoS One. 2021 May 26;16(5):e0251967. doi: 10.1371/journal.pone.0251967. PMID: 34038457; PMCID: PMC8153482.
  17. Otgontuya D, Oum S, Buckley BS, Bonita R. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health. 2013 Jun 5;13:539. doi: 10.1186/1471-2458-13-539. PMID: 23734670; PMCID: PMC3679976.
  18. Khanal MK, Ahmed MS, Moniruzzaman M, Banik PC, Dhungana RR, Bhandari P, Devkota S, Shayami A. Total cardiovascular risk for next 10 years among rural population of Nepal using WHO/ISH risk prediction chart. BMC Res Notes. 2017 Mar 7;10(1):120. doi: 10.1186/s13104-017-2436-9. PMID: 28270186; PMCID: PMC5341399.
  19. Al-Mawali A, Al-Harrasi A, Pinto AD, Jayapal SK, Morsi M, Al-Shekaili W, Al-Kharusi H, Idikula J. Assessment of Total Cardiovascular Risk Using WHO/ISH Risk Prediction Chart Among Adults in Oman: A Nationally Representative Survey. Oman Med J. 2023 May 31;38(3):e501. doi: 10.5001/omj.2023.70. PMID: 37496864; PMCID: PMC10366652.
  20. Kubota Y, Heiss G, MacLehose RF, Roetker NS, Folsom AR. Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. JAMA Intern Med. 2017 Aug 1;177(8):1165-1172. doi: 10.1001/jamainternmed.2017.1877. PMID: 28604921; PMCID: PMC5710437.

Download Article
Received February 8, 2024.
Accepted March 21, 2024.
©2024 International Medical Research and Development Corporation.